FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938286893> ?p ?o ?g. }

• W2938286893 endingPage "e027535" @default.
• W2938286893 startingPage "e027535" @default.
• W2938286893 abstract "Objectives This analysis examined the association between psoriasis severity, assessed by body surface area (BSA) and the Investigator’s Global Assessment (IGA; previously used only in clinical trials), and patient-reported outcomes (PROs) in a real-world setting. Design Cross-sectional analysis within the Corrona Psoriasis Registry, an independent, prospective registry. Setting 70 dermatology practices in the USA. Participants 1529 adult patients with psoriasis being treated with biological or non-biological systemic psoriasis treatment by 31 May 2016. Primary and secondary outcome measures Psoriasis severity was assessed by percentage of affected BSA (mild (0%–5%), moderate (>5%–10%), severe (>10%–15%), very severe (>15%)) and IGA scores (clear/almost clear (0–1), mild (2), moderate (3), severe (4)). PROs (pain, itch, fatigue; Dermatology Life Quality Index [DLQI]; EuroQoL Visual Analogue Scale [EQ-VAS]; Work Productivity and Activity Impairment [WPAI]) were compared across BSA and IGA levels using analysis of variance and X 2 tests. The association between psoriasis severity and PROs was examined using multivariable regression models. Results The mean age was 50.6 years and 47% of patients were female. Consistently with more severe psoriasis, symptoms worsened, DLQI scores increased (p<0.05 for each level of BSA and IGA), EQ-VAS decreased (p<0.05 for each level of BSA and IGA) and WPAI scores increased. By BSA score, moderate to very severe psoriasis was associated with poorer outcomes for the ‘impairment while working’ and ‘daily activities impaired’ WPAI domains (all p<0.05 vs mild psoriasis). Very severe psoriasis was associated with increased ‘work hours missed’ and ‘work hours affected’ (both p<0.05 vs mild psoriasis) Findings were similar by IGA. Results were confirmed by multivariable regression analyses. Conclusions In a real-world setting, more severe psoriasis, assessed by BSA and IGA, was consistently associated with worse PROs." @default.
• W2938286893 created "2019-04-25" @default.
• W2938286893 creator A5000045044 @default.
• W2938286893 creator A5001211507 @default.
• W2938286893 creator A5012501013 @default.
• W2938286893 creator A5015696460 @default.
• W2938286893 creator A5024826482 @default.
• W2938286893 creator A5030768494 @default.
• W2938286893 creator A5038505651 @default.
• W2938286893 creator A5050416837 @default.
• W2938286893 creator A5065966188 @default.
• W2938286893 creator A5091485944 @default.
• W2938286893 date "2019-04-01" @default.
• W2938286893 modified "2023-10-16" @default.
• W2938286893 title "Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry" @default.
• W2938286893 cites W1866625480 @default.
• W2938286893 cites W1963627597 @default.
• W2938286893 cites W1971301895 @default.
• W2938286893 cites W1971982162 @default.
• W2938286893 cites W2017932566 @default.
• W2938286893 cites W2071725181 @default.
• W2938286893 cites W2086325363 @default.
• W2938286893 cites W2096991001 @default.
• W2938286893 cites W2103120331 @default.
• W2938286893 cites W2121623213 @default.
• W2938286893 cites W2122115277 @default.
• W2938286893 cites W2126689331 @default.
• W2938286893 cites W2128551077 @default.
• W2938286893 cites W2145628010 @default.
• W2938286893 cites W2152262899 @default.
• W2938286893 cites W2257545295 @default.
• W2938286893 cites W2327252657 @default.
• W2938286893 cites W2473786944 @default.
• W2938286893 cites W2558385573 @default.
• W2938286893 cites W2575563373 @default.
• W2938286893 cites W2742484040 @default.
• W2938286893 cites W2771621536 @default.
• W2938286893 doi "https://doi.org/10.1136/bmjopen-2018-027535" @default.
• W2938286893 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6500315" @default.
• W2938286893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31005939" @default.
• W2938286893 hasPublicationYear "2019" @default.
• W2938286893 type Work @default.
• W2938286893 sameAs 2938286893 @default.
• W2938286893 citedByCount "37" @default.
• W2938286893 countsByYear W29382868932019 @default.
• W2938286893 countsByYear W29382868932020 @default.
• W2938286893 countsByYear W29382868932021 @default.
• W2938286893 countsByYear W29382868932022 @default.
• W2938286893 countsByYear W29382868932023 @default.
• W2938286893 crossrefType "journal-article" @default.
• W2938286893 hasAuthorship W2938286893A5000045044 @default.
• W2938286893 hasAuthorship W2938286893A5001211507 @default.
• W2938286893 hasAuthorship W2938286893A5012501013 @default.
• W2938286893 hasAuthorship W2938286893A5015696460 @default.
• W2938286893 hasAuthorship W2938286893A5024826482 @default.
• W2938286893 hasAuthorship W2938286893A5030768494 @default.
• W2938286893 hasAuthorship W2938286893A5038505651 @default.
• W2938286893 hasAuthorship W2938286893A5050416837 @default.
• W2938286893 hasAuthorship W2938286893A5065966188 @default.
• W2938286893 hasAuthorship W2938286893A5091485944 @default.
• W2938286893 hasBestOaLocation W29382868931 @default.
• W2938286893 hasConcept C126322002 @default.
• W2938286893 hasConcept C14184104 @default.
• W2938286893 hasConcept C159110408 @default.
• W2938286893 hasConcept C16005928 @default.
• W2938286893 hasConcept C1862650 @default.
• W2938286893 hasConcept C2776173921 @default.
• W2938286893 hasConcept C2777501473 @default.
• W2938286893 hasConcept C2779951463 @default.
• W2938286893 hasConcept C2780564577 @default.
• W2938286893 hasConcept C30036603 @default.
• W2938286893 hasConcept C71924100 @default.
• W2938286893 hasConceptScore W2938286893C126322002 @default.
• W2938286893 hasConceptScore W2938286893C14184104 @default.
• W2938286893 hasConceptScore W2938286893C159110408 @default.
• W2938286893 hasConceptScore W2938286893C16005928 @default.
• W2938286893 hasConceptScore W2938286893C1862650 @default.
• W2938286893 hasConceptScore W2938286893C2776173921 @default.
• W2938286893 hasConceptScore W2938286893C2777501473 @default.
• W2938286893 hasConceptScore W2938286893C2779951463 @default.
• W2938286893 hasConceptScore W2938286893C2780564577 @default.
• W2938286893 hasConceptScore W2938286893C30036603 @default.
• W2938286893 hasConceptScore W2938286893C71924100 @default.
• W2938286893 hasFunder F4320307778 @default.
• W2938286893 hasIssue "4" @default.
• W2938286893 hasLocation W29382868931 @default.
• W2938286893 hasLocation W29382868932 @default.
• W2938286893 hasLocation W29382868933 @default.
• W2938286893 hasLocation W29382868934 @default.
• W2938286893 hasOpenAccess W2938286893 @default.
• W2938286893 hasPrimaryLocation W29382868931 @default.
• W2938286893 hasRelatedWork W1892203605 @default.
• W2938286893 hasRelatedWork W2001015070 @default.
• W2938286893 hasRelatedWork W2417573846 @default.
• W2938286893 hasRelatedWork W2754068115 @default.
• W2938286893 hasRelatedWork W2766413417 @default.
• W2938286893 hasRelatedWork W3084498249 @default.
• W2938286893 hasRelatedWork W4205675137 @default.

• next